Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Palbociclib
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Tazemetostat and Palbociclib With CPX-351for R/R AML
- Status
- RECRUITING
- Phase
- PHASE1
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Status
- RECRUITING
- Phase
- PHASE2
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pilot Trial for Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
- Status
- COMPLETED
- Phase
- N/A
Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
SMMART Adaptive Clinical Treatment (ACT) Trial
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)
- Status
- COMPLETED
- Phase
- PHASE1
Avelumab, Palbociclib and Axitinib in Advanced RCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A